Clinical review report: Emtricitabine/tenofovir alafenamide fumarate (Descovy)
The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediat...
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, April 2016
|
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this systematic review was to evaluate of the beneficial and harmful effects of the fixed-dose combination of emtricitabine/tenofovir alafenamide fumarate in combination with other antiretrovirals for the treatment of human immunodeficiency virus(HIV)-1 infection in adult and pediatric patients 12 years of age and older (and weighing ≥ 35 kg) |
---|---|
Physical Description: | 1 PDF file (xiii, 69 pages) illustrations |